Lyrica
Pricing Report NDC 0071-1017-68

Current NADAC: $9.69323 per EA · Effective Jul 22, 2026 · Est. package price $872.39 (90 EA)

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The current wholesale acquisition cost for Lyrica (NDC 0071-1017-68) is $9.69323 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jul 22, 2026.

As a provided by Parke-davis Div Of Pfizer Inc, this medication is distributed in a 90 CAPSULE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$9.69323
Per EA

Effective Date
Jul 22, 2026
Billable Units
90 EA
Estimated Package Price
$872.39
Data Status
As of Jul 29, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
90 CAPSULE in 1 BOTTLE
Generic Benchmark
The generic equivalent rate is $0.05638 (Effective: Jul 22, 2026)
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jul 2013, the NADAC wholesale price for (NDC ) has moved within a range of $3.59022 to $9.70999 per EA. Over this 13 years period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$3.5902 - $9.7100
Market Volatility
170.46% Variance
Latest Trend
0.02%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Jul 22, 2026 $9.69323 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jun 17, 2026 $9.69491 EAC/I - Chain or Independent PharmacyCode 1B - Brand
May 20, 2026 $9.69674 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Apr 22, 2026 $9.69617 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Mar 18, 2026 $9.70235 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Feb 18, 2026 $9.70183 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jan 21, 2026 $9.70171 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Dec 17, 2025 $9.70175 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Nov 19, 2025 $9.70303 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Oct 22, 2025 $9.70999 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jul 23, 2025 $9.70600 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jul 23, 2025 $9.70600 EAC/I - Chain or Independent PharmacyCode 2B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026